Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
IBRX2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in IMMUNITYBIO INC
Yes. Vanguard Portfolio Management holds 17,863,911 shares of IBRX (Immunitybio), worth $156.4M, as of its Q2 2026 13F filing. It increased the position by 1,541,067 shares (+9.4%) from Q1 2026. Vanguard Portfolio Management has held IBRX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$156.4M
Current Shares
17.9M
Total Value Change
+$31.2M
Total Shares Change
+1.5M
Quarter-by-Quarter History
Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC